Treatment analysis
The disease is active, or you want a second look.
$5,000 to $8,000per patient, including expanded-access work when it is needed
- Whole-exome DNA and RNA analysis of the tumor, against a matched normal sample
- Every therapy the biology supports, graded by evidence: approved, off-label, trials, and expanded access
- The way in for each option, prepared for your physician before it is needed
- The case re-checked as new trials and evidence appear, for as long as we are on it
Starts from an existing sequencing report. If there is none yet, we talk through the options first.